Clinical trials
Breast Neoplasms trials in Greece with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Harokopio University | 3 |
| Aristotle University Of Thessaloniki | 2 |
| National and Kapodistrian University of Athens | 2 |
| University Hospital, Basel, Switzerland | 2 |
| Aalborg University | 1 |
| Aretaieion University Hospital | 1 |
| Centre for Research and Technology Hellas | 1 |
| ETOP IBCSG Partners Foundation | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Iaso Maternity Hospital, Athens, Greece | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 21 |
| Chronic Pain | 2 |
| Neoplasms | 2 |
| Postoperative Pain | 2 |
| Prostatic Neoplasms | 2 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Cardiovascular Diseases | 1 |
| Colonic Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Dyspareunia | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.